Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.09
-0.53 (-6.96%)
Dec 5, 2025, 4:00 PM EST - Market closed
Bioventus Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$13.33
Upside
+88.01%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $12 | Buy | Initiates | $12 | +69.25% | Jul 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +111.57% | Mar 17, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +83.36% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +111.57% | Nov 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +139.77% | Sep 27, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +69.25% | Aug 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $9 → $12 | Strong Buy | Maintains | $9 → $12 | +69.25% | Aug 7, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +12.83% | May 8, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $6 → $9 | Strong Buy | Maintains | $6 → $9 | +26.94% | Mar 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold → Strong Buy Upgrades $3.66 → $7 | Hold → Strong Buy | Upgrades | $3.66 → $7 | -1.27% | Dec 7, 2023 |
| Craig-Hallum | Craig-Hallum | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | -29.48% | Apr 3, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $13 → $2.5 | Hold | Maintains | $13 → $2.5 | -64.74% | Nov 30, 2022 |
| Craig-Hallum | Craig-Hallum | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 22, 2022 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $11 → $5 | Buy | Maintains | $11 → $5 | -29.48% | Nov 10, 2022 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 9, 2022 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades n/a | Buy → Sell | Downgrades | n/a | n/a | Nov 9, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.